Health knowledge made personal
Join this community!
› Share page:
Go
Search posts:

Study : A common X-linked inborn error of carnitine biosynthesis may be a risk factor for nondysmorphic autism.

Posted May 13 2012 11:29am
It isn't often that I read a paper on autism that presents a complete picture of what autism might be (for some people) from genetic cause to biological pathways to possible treatment.  But a paper on an inborn error of carnitine biosynthesis from last week might fit the bill.

This paper ties together a genetic mutation, the effect of the mutation on the body's biological pathways, possible dietary factors in early childhood, and hints at a possible way to treat existing autism or to decrease the risk of autism developing in the first place.

The abstract is below and, if you are interested, the study text is open access and available here .

A common X-linked inborn error of carnitine biosynthesis may be a risk factor fornondysmorphic autism.

We recently reported a deletion of exon 2 of the trimethyllysine hydroxylase epsilon (TMLHE) gene in a proband with autism. TMLHE maps to the X chromosome and encodes the first enzyme in carnitine biosynthesis, 6-N-trimethyllysine dioxygenase. Deletion of exon 2 of TMLHE causes enzyme deficiency, resulting in increased substrate concentration (6-N-trimethyllysine) and decreased product levels (3-hydroxy-6-N-trimethyllysine and ?-butyrobetaine) in plasma and urine. TMLHE deficiency is common in control males (24 in 8,787 or 1 in 366) and was not significantly increased in frequency in probands from simplex autism families (9  in 2,904 or 1 in 323). However, it was 2.82-fold more frequent in probands from male-male multiplex autism families compared with controls (7 in 909 or 1 in 130; P = 0.023). Additionally, six of seven autistic male siblings of probands in male-male multiplex families had the deletion, suggesting that TMLHE deficiency is a risk factor for autism (metaanalysis Z-score = 2.90 and P = 0.0037), although with low penetrance (2-4%). These data suggest that dysregulation of carnitine metabolism may be important in nondysmorphic autism; that abnormalities of carnitine intake, loss, transport, or synthesis may be important in a larger fraction of nondysmorphic autism cases; and that the carnitine pathway may provide a novel target for therapy or prevention of autism.


References

Celestino-Soper PB, Violante S, Crawford EL, Luo R, Lionel AC, Delaby E, Cai G, Sadikovic B, Lee K, Lo C, Gao K, Person RE, Moss TJ, German JR, Huang N, Shinawi M, Treadwell-Deering D, Szatmari P, Roberts W, Fernandez B, Schroer RJ, Stevenson RE, Buxbaum JD, Betancur C, Scherer SW, Sanders SJ, Geschwind DH, Sutcliffe JS, Hurles ME, Wanders RJ, Shaw CA, Leal SM, Cook EH Jr, Goin-Kochel RP, Vaz FM, Beaudet AL. A common X-linked inborn error of carnitine biosynthesis  may be a risk factor for nondysmorphic autism. Proc Natl Acad Sci U S A. 2012 May 7. [Epub ahead of print]
PubMed PMID: 22566635 .
Post a comment
Write a comment:

Related Searches